Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

J. Hammarsten; J-E Damber; Magnus Karlsson; T. Knutson; O. Ljunggren; C. Ohlsson; R. Peeker; U. Smith; D. Mellstrom

doi:10.1038/pcan.2008.50

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

J. Hammarsten, J-E Damber, Magnus Karlsson, T. Knutson, O. Ljunggren, C. Ohlsson, R. Peeker, U. Smith, D. Mellstrom

Orthopedics

Research output: Contribution to journal › Article › peer-review

Abstract

The aetiology of benign prostatic hyperplasia (BPH) remains unclear. The objective of the present study was to test the insulin, oestradiol and metabolic syndrome hypotheses as promoters of BPH. The design was a risk factor analysis of BPH in which the total prostate gland volume was related to endocrine and anthropometric factors. The participants studied were 184 representative men, aged 72-76 years, residing in Goteborg, Sweden. Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum insulin (beta = 0.200, P = 0.028), free oestradiol (beta = 0.233, P = 0.008) and lean body mass (beta = 0.257, P = 0.034). Insulin and free oestradiol appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses. Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH. Prostate Cancer and Prostatic Diseases (2009) 12, 160-165; doi:10.1038/pcan.2008.50; published online 30 September 2008

Original language	English
Pages (from-to)	160-165
Journal	Prostate Cancer and Prostatic Diseases
Volume	12
Issue number	2
DOIs	https://doi.org/10.1038/pcan.2008.50
Publication status	Published - 2009

Subject classification (UKÄ)

Gynaecology, Obstetrics and Reproductive Medicine

Free keywords

lean body mass
benign prostatic hyperplasia
insulin
oestradiol
the
metabolic syndrome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/pcan.2008.50

Cite this

@article{7f99a167f5024f67993da66b4f358bde,

title = "Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia",

abstract = "The aetiology of benign prostatic hyperplasia (BPH) remains unclear. The objective of the present study was to test the insulin, oestradiol and metabolic syndrome hypotheses as promoters of BPH. The design was a risk factor analysis of BPH in which the total prostate gland volume was related to endocrine and anthropometric factors. The participants studied were 184 representative men, aged 72-76 years, residing in Goteborg, Sweden. Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum insulin (beta = 0.200, P = 0.028), free oestradiol (beta = 0.233, P = 0.008) and lean body mass (beta = 0.257, P = 0.034). Insulin and free oestradiol appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses. Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH. Prostate Cancer and Prostatic Diseases (2009) 12, 160-165; doi:10.1038/pcan.2008.50; published online 30 September 2008",

keywords = "lean body mass, benign prostatic hyperplasia, insulin, oestradiol, the, metabolic syndrome",

author = "J. Hammarsten and J-E Damber and Magnus Karlsson and T. Knutson and O. Ljunggren and C. Ohlsson and R. Peeker and U. Smith and D. Mellstrom",

year = "2009",

doi = "10.1038/pcan.2008.50",

language = "English",

volume = "12",

pages = "160--165",

journal = "Prostate Cancer and Prostatic Diseases",

issn = "1476-5608",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

AU - Hammarsten, J.

AU - Damber, J-E

AU - Karlsson, Magnus

AU - Knutson, T.

AU - Ljunggren, O.

AU - Ohlsson, C.

AU - Peeker, R.

AU - Smith, U.

AU - Mellstrom, D.

PY - 2009

Y1 - 2009

N2 - The aetiology of benign prostatic hyperplasia (BPH) remains unclear. The objective of the present study was to test the insulin, oestradiol and metabolic syndrome hypotheses as promoters of BPH. The design was a risk factor analysis of BPH in which the total prostate gland volume was related to endocrine and anthropometric factors. The participants studied were 184 representative men, aged 72-76 years, residing in Goteborg, Sweden. Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum insulin (beta = 0.200, P = 0.028), free oestradiol (beta = 0.233, P = 0.008) and lean body mass (beta = 0.257, P = 0.034). Insulin and free oestradiol appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses. Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH. Prostate Cancer and Prostatic Diseases (2009) 12, 160-165; doi:10.1038/pcan.2008.50; published online 30 September 2008

AB - The aetiology of benign prostatic hyperplasia (BPH) remains unclear. The objective of the present study was to test the insulin, oestradiol and metabolic syndrome hypotheses as promoters of BPH. The design was a risk factor analysis of BPH in which the total prostate gland volume was related to endocrine and anthropometric factors. The participants studied were 184 representative men, aged 72-76 years, residing in Goteborg, Sweden. Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum insulin (beta = 0.200, P = 0.028), free oestradiol (beta = 0.233, P = 0.008) and lean body mass (beta = 0.257, P = 0.034). Insulin and free oestradiol appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses. Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH. Prostate Cancer and Prostatic Diseases (2009) 12, 160-165; doi:10.1038/pcan.2008.50; published online 30 September 2008

KW - lean body mass

KW - benign prostatic hyperplasia

KW - insulin

KW - oestradiol

KW - the

KW - metabolic syndrome

U2 - 10.1038/pcan.2008.50

DO - 10.1038/pcan.2008.50

M3 - Article

C2 - 18825163

SN - 1476-5608

VL - 12

SP - 160

EP - 165

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

IS - 2

ER -

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

Abstract

Subject classification (UKÄ)

Free keywords

UN SDGs

Access to Document

Fingerprint

Cite this